{{Rsnum
|rsid=1053667
|Gene=FAM179B
|Chromosome=14
|position=45073835
|Orientation=plus
|GMAF=0.129
|Gene_s=FAM179B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 6.2 | 92.9
| HCB | 0.7 | 19.0 | 80.3
| JPT | 4.5 | 28.6 | 67.0
| YRI | 5.4 | 42.9 | 51.7
| ASW | 7.0 | 43.9 | 49.1
| CHB | 0.7 | 19.0 | 80.3
| CHD | 0.9 | 20.2 | 78.9
| GIH | 2.0 | 23.8 | 74.3
| LWK | 7.3 | 46.4 | 46.4
| MEX | 1.7 | 17.2 | 81.0
| MKK | 7.1 | 39.1 | 53.8
| TSI | 0.0 | 16.7 | 83.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24530479
|Title=A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma
}}

{{PMID Auto
|PMID=17584784
|Title=Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
|OA=1
}}

{{PMID Auto
|PMID=22539802
|Title=Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
}}

{{PMID Auto
|PMID=24831772
|Title=A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}